Healios KK (TSE:4593) FCF Yield %: -10.97 (As of Jul. 11, 2026)


TSE:4593 Healios KK TSE:4593
53 GF Score
Price 円261.00
GF Value 円56.74
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Healios KK FCF Yield %?

Healios KK TSE:4593 +1.95% 53 FCF Yield % is -10.97 as of Jul. 11, 2026. GuruFocus rates TSE:4593 with a GF Score™ of 53/100 and a GF Value™ of 円56.74 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,408 Biotechnology companies, Healios KK ranks worse than 54.19% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Healios KK's Trailing 12-Month Free Cash Flow is 円-3,865.00 Mil, and Market Cap is 円35,235.50 Mil. Therefore, Healios KK's FCF Yield % for today is -10.97%.

The historical rank and industry rank for Healios KK's FCF Yield % or its related term are showing as below:

TSE:4593' s FCF Yield % Range Over the Past 10 Years
Min: -40.05   Med: -7.38   Max: -1.44
Current: -10.97


During the past 12 years, the highest FCF Yield % of Healios KK was -1.44%. The lowest was -40.05%. And the median was -7.38%.

TSE:4593's FCF Yield % is ranked worse than
54.19% of 1408 companies
in the Biotechnology industry
Industry Median: -9.41 vs TSE:4593: -10.97

Healios KK's FCF Margin % for the quarter that ended in Mar. 2026 was -16,325.00%.


Healios KK FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Healios KK FCF Yield % Related Terms


Healios KK FCF Yield % Historical Data

* Premium members only.

The historical data trend for Healios KK's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healios KK FCF Yield % Chart

Healios KK Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.62 -28.71 -23.17 -13.30 -10.51

Healios KK Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.26 -6.51 -5.37 -11.74 -10.32

TSE:4593 vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Healios KK's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healios KK FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Healios KK's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Healios KK's FCF Yield % falls into.


TSE:4593
53GF Score
Healios KK TSE:4593
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Healios KK FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Healios KK's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-3333 / 31709.198
=-10.51%

Healios KK's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1306 * 4 / 50625.75
=-10.32%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -10.97 mean?
Healios KK (TSE:4593) has a FCF Yield % of -10.97 as of Jul. 11, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Healios KK and its competitors. According to the industry distribution chart, Healios KK ranks #763 out of 1408 companies in the Biotechnology industry, placing it in the top 54.2%.
Is Healios KK's FCF Yield % too high?
Healios KK's current FCF Yield % is -10.97. Based on the distribution chart, Healios KK ranks #763 out of 1408 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Healios KK has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Healios KK's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Healios KK ranks #763 out of 1408 companies for FCF Yield %. This places Healios KK in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Healios KK and its competitors. Healios KK's current FCF Yield % is -10.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healios KK stock overvalued right now?
Based on GuruFocus' analysis, Healios KK (TSE:4593) is currently considered Significantly Overvalued. The stock's GF Value™ is 円56.74, compared to a current price of 円261.00 — trading 360% above its estimated fair value. The current FCF Yield % is -10.97. Healios KK's overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Healios KK (TSE:4593), the current FCF Yield % is -10.97 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healios KK (TSE:4593) Overvalued in 2026?

Based on GuruFocus' analysis, Healios KK stock appears to be overvalued. The current stock price of 円261.00 is trading 360% above its estimated GF Value™ of 円56.74. GuruFocus considers Healios KK to be Significantly Overvalued.

Key valuation signals for TSE:4593:

  • FCF Yield %: -10.97
  • GF Value™: 円56.74 vs. price of 円261.00 (360% above fair value)
  • GF Score™: 53/100 with 5 warning signs

No single metric tells the full story. See the TSE:4593 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Healios KK Business Description

Other Exchanges HLOSF:USA6VX:Germany
Address 1-1-2 Yurakucho, Hibiya Mitsui Tower 12Floor, Work Styling, Chiyoda-ku, Tokyo, JPN, 100-0006
Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products. The company is developing treatments for age-related macular degeneration and organ anlage transplantation therapy. The company develops next-generation cell therapies using a proprietary gene-edited induced pluripotent stem cell (iPSC) platform, with programs targeting immuno-oncology, ophthalmology, liver diseases, ischemic stroke, and acute respiratory distress syndrome.
53GF Score

Get the complete analysis for TSE:4593

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円261.00
Price
円56.74
GF Value